mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.081 |
0.1 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.27 |
0.1 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.1 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |